Agilent Technologies, Inc. (NYSE:A) Holdings Cut by Rice Partnership LLC

Rice Partnership LLC lowered its holdings in Agilent Technologies, Inc. (NYSE:A) by 6.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,049 shares of the medical research company’s stock after selling 131 shares during the period. Rice Partnership LLC’s holdings in Agilent Technologies were worth $275,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies during the third quarter valued at approximately $28,000. CKW Financial Group raised its holdings in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after purchasing an additional 100 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies during the third quarter worth approximately $31,000. Fortitude Family Office LLC raised its holdings in Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after purchasing an additional 95 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new stake in Agilent Technologies during the third quarter worth approximately $38,000.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on A. Bank of America dropped their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Barclays dropped their target price on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a report on Wednesday, November 27th. Citigroup boosted their target price on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. Sanford C. Bernstein decreased their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday, November 26th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $143.62.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Agilent Technologies Stock Up 0.2 %

Agilent Technologies stock opened at $151.75 on Monday. The firm has a market cap of $43.34 billion, a price-to-earnings ratio of 34.33, a P/E/G ratio of 4.10 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. Agilent Technologies, Inc. has a fifty-two week low of $124.16 and a fifty-two week high of $155.35. The firm has a fifty day moving average price of $140.52 and a two-hundred day moving average price of $138.85.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business’s revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.38 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st were issued a dividend of $0.248 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.65%. Agilent Technologies’s payout ratio is presently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.